References
- Pellegrino R, Viegi G, Brusasco V, Interpretative strategies for lung function tests. Eur Respir J 2005; 26(5):948–68.
- Quanjer PH, Enright PL, Miller MR, Open letter: the need to change the method for defining mild airway obstruction. Prim Care Respir J 2010; 19(3):288–91.
- Miller MR, Quanjer PH, Swanney MP, Ruppel G, Enright PL. Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest 2011;139(1):52–59.
- Watanabe S, Renzetti AD, Jr., Begin R, et al. Airway responsiveness to a bronchodilator aerosol. I. Normal human subjects. Am Rev Respir Dis 1974; 109(5):530–7.
- Lorber DB, Kaltenborn W, Burrows B. Responses to isoproterenol in a general population sample. Am Rev Respir Dis 1978; 118(5):855–61.
- Dales RE, Spitzer WO, Tousignant P, Clinical interpreta-tion of airway response to a bronchodilator. Epidemiologic considerations. Am Rev Respir Dis 1988; 138(2):317–20.
- Kainu A, Lindqvist A, Sarna S, FEV1 response to bronchodila-tion in an adult urban population. Chest 2008; 134(2):387–93.
- European Respiratory Society. Standardized lung function testing. Official statement of the European Respiratory Society [see comments]. Eur Respir J Suppl 1993; 16:1–100.
- Levy ML, Quanjer PH, Booker R, Diagnostic spirometry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: a General Practice Airways Group (GPIAG)1 document, in association with the Association for Respiratory Technology & Physiology (ARTP)2 and Education for Health3 1 www.gpiag.org 2 www.artp.org 3 www.educationforhealth.org.uk. Prim Care Respir J 2009; 18(3):130–47.
- Prentice HA, Mannino DM, Caldwell GG, Significant bronchodilator responsiveness and “reversibility” in a population sample. COPD 2010; 7(5):323–30.
- Johannessen A, Omenaas ER, Bakke PS, Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: A community study. Thorax 2005; 60(10):842–7.
- GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (revised 2011). full text: http://www.goldcopd.com. 2011.
- Tashkin DP, Celli B, Decramer M, Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008; 31(4):742–50.
- Global Strategy for Asthma Management and Prevention 2010 (update); full text: http://www.ginasthma.com, 2010.